C5a Complement Peptide Receptor 1 Antibodies
C5a1 is the specific receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a. Receptor activation stimulates chemotaxis, granule enzyme release, intracellular calcium release and superoxide anion production in macrophages and other immune cells. The development of potent and selective antagonists has been proposed as a strategy for new anti-inflammatory compounds for diseases in which damage by neutrophils plays a key role. C5a1 desensitization, β-arrestin recruitment and internalization is regulated by phosphorylation of carboxyl-terminal threonine324/serine327 (pT324/pS327-C5a1) and serine332/serine334 (pS332/pS334-C5a1) residues. This nomenclature refers to the human C5a1 receptor. This phosphorylation motif is conserved across species but corresponds to pS325/pS328-C5a1 and pS333/pS335-C5a1 in mice and pS325/pS328-C5a1 and pS334/pS336-C5a1 in rats. T324/S327 are also subject to phosphorylation by PKC. For more information on C5a1 receptor pharmacology please refer to the IUPHAR database. For further reading refer to:
Klos A, Wende E, Wareham KJ, Monk PN. International Union of Basic and Clinical Pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors. Pharmacol Rev. 2013 Jan;65(1):500-43. Review. Erratum in: Pharmacol Rev. 2014 Apr;66(2):466. PubMed PMID: 23383423.
Nürge B, Schulz AL, Kaemmerer D, Sänger J, Evert K, Schulz S, Lupp A. Immunohistochemical identification of complement peptide C5a receptor 1 (C5aR1) in non-neoplastic and neoplastic human tissues. PLoS One. 2021 Feb 19;16(2):e0246939. doi: 10.1371/journal.pone.0246939. PMID: 33606748; PMCID: PMC7894821.